{
    "Trade/Device Name(s)": [
        "ARCHITECT HAVAB-G",
        "ARCHITECT HAVAB-G Calibrator Kit",
        "ARCHITECT HAVAB-G Control Kit"
    ],
    "Submitter Information": "Abbott Laboratories Diagnostics Division",
    "510(k) Number": "K113704",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063329"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LOL",
        "MJY",
        "MJX",
        "JIS"
    ],
    "Summary Letter Date": "June 28, 2012",
    "Summary Letter Received Date": "May 18, 2012",
    "Submission Date": "May 18, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.3310",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Hepatitis A virus (HAV) serological assays",
        "Calibrator",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "virology",
        "serology"
    ],
    "Analyte(s)": [
        "IgG anti-HAV (IgG antibody to hepatitis A virus)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescence"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent Kit"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT HAVAB-G chemiluminescent immunoassay for qualitative detection of hepatitis A IgG antibody in serum",
    "Indications for Use Summary": "Qualitative detection of IgG antibody to hepatitis A virus in human adult and pediatric serum to determine immune status; not for blood/plasma donor screening or acute HAV diagnosis",
    "fda_folder": "Microbiology"
}